Resistance to Rifampin and Lysozyme of Strains of Some Species of Mycobacterium and Nocardia as a Taxonomic Tool

References

1. Arioli V., Pallanza R., Furesz S., Carniti G. 1967; Rifampicin: a new rifamycin. I. Bacteriological studies. Arzneim. Forsch. 17:523–528
   [Google Scholar]
2. Clark J., Wallace A. 1967; The susceptibility of mycobacteria to rifamide and rifampicin. Tubercle 48:144–150
   [Google Scholar]
3. Denis-Bottin C. 1972; Activité ((in vitro)) de la rifampicine sur des souches de mycobactéries tuberculeuses et atypiques. Acta Tuberc. Pneumol. Belg. 63:127–139
   [Google Scholar]
4. Goodfellow M., Orchard V. A. 1974; Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy. J. Gen. Microbiol. 83:375–387
   [Google Scholar]
5. Gordon R. E., Barnett D. A., Handerhan J. E., Pang C. H.-N. 1974; Nocardia coeliaca, Nocardia autotrophica, and the nocardin strain. Int. J. Syst. Bacteriol. 24:54–63
   [Google Scholar]
6. Hennebert A. 1969; Activité antimycobactérienne de la rifampicine «in vitro)) dans différents milieux. Acta Tuberc. Pneumol. Belg. 60:348–354
   [Google Scholar]
7. Hobby G. L., Lenert T. F. 1968; The antimycobacterial activity of rifampin. Am. Rev. Respir. Dis. 97:713–714
   [Google Scholar]
8. Hobby G. L., Lenert T. F., Maier-Engallena J. 1969; Experimental observations on the antimycobacterial activity of rifampin. Proc. Soc. Exp. Biol. Med. 131:323–326
   [Google Scholar]
9. Jenne J. W., Beggs W. H. 1973; Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin. Am. Rev. Respir. Dis. 107:1013–1021
   [Google Scholar]
10. Karlson A. G. 1970; Comparison of three mediums for rifampin-susceptibility tests of mycobacteria. Am. Rev. Respir. Dis. 101:765–767
    [Google Scholar]
11. Le Lirzin M., Boisvert H. 1971; Teneur des souches de mycobactéries atypiques, pathogènes pour l’homme, en variants résistant a la rifampicine et en variants résistant a l’éthambutol, sur milieu de Loewenstein-Jensen. Ann. Inst. Pasteur Paris 120:549–559
    [Google Scholar]
12. Lorian V., Finland M. 1969; In vitro effect of rifampin on mycobacteria. Appl. Microbiol 17:202207
    [Google Scholar]
13. Lucchesi M., Mancini P. 1970; Antimycobacterial activity of rifampicin. Antibiot. Chemother 16:431443
    [Google Scholar]
14. McClatchy J. K., Waggoner R. F., Lester W. 1969; In vitro susceptibility of mycobacteria to rifampin. Am. Rev. Respir. Dis. 100:234–236
    [Google Scholar]
15. Manten A., van Wijngaarden L. J., van Klingeren B. 1969; Rifampicin-susceptibility and rifampicin-resistance in mycobacteria. Acta Tuberc. Pneumol. Belg. 60:329–334
    [Google Scholar]
16. Molavi A., Weinstein L. 1971; In vitro susceptibility of atypical mycobacteria to rifampin. Appi. Microbiol. 22:23–25
    [Google Scholar]
17. Nitti V. 1970; Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs. Antibiot. Chemother 16:444470
    [Google Scholar]
18. Nitti V., Catena E., Ninni A., Di Filippo A. 1966; Indagini sperimentali sull’attività antimicobatterica della rifampicina. Arch. Tisiol. Pneumol. (Montevideo) 21:867–910
    [Google Scholar]
19. Pallanza R., Arioli V., Furesz S., Bolzoni G. 1967; Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations. Arzneim. Forsch 17:529534
    [Google Scholar]
20. Rynearson T. K., Shrontis J. S., Woiinsky E. 1971; Rifampin: in vitro effect on atypical mycobacteria. Am. Rev. Respir. Dis. 104:272–274
    [Google Scholar]
21. Schröder K. H., Hensel J., Scheuch V. 1969; Die Sensibilitätsprüfung von M. tuberculosis und atypischen Mykobakterien gegen Ethambutol, Capreomycin und Rifampicin. Prax. Pneumol. 23:683–694
    [Google Scholar]
22. Tacquet A., Devulder B., Martin J. C., Daniel H., Le Bouffant L. 1969; Activité antimycobactérienne de la rifampicine: etudes ((in vitro)) et «in vivo)). Acta Tuberc. Pneumol. Belg. 60:366–389
    [Google Scholar]
23. Tanzil H. O. K., Chatim A., Rachim A., Judanarso D. 1972; ((In vitro)) action of rifampicin on typical and atypical mycobacteria. Acta Tuberc. Pneumol. Belg. 63:140–147
    [Google Scholar]
24. Verbiet L., Gyselen A. 1968; Antituberculosis activity of rifampin in vitro and in vivo and the concentrations attained in human blood. Am. Rev. Respir. Dis. 98:923–932
    [Google Scholar]
25. Zierski M., Wozniak S., Tomaszkiewicz L. 1969; The antimycobacterial activity of rifampicin ((in vitro)). Acta Tuberc. Pneumol. Belg. 60:341–347
    [Google Scholar]